Top Tweets for #comydal
Outstanding talk by Professor @SKordasti in #IACH2025 #ComyDAL meeting in Paris on immune targeting in #MDSsm
Best team leading IACH dayS in paris #colym #comydal #mpncod @AnnaSureda5 @Dr_AmerZeidan @Mohty_EBMT and Arnon Nagler
CONGRESS | #IACH23 | #CoMyDAL @SridharChaganti, @uhbtrust discusses the role of CAR T-cell therapy in ALL and the indications for transplantation according to cytogenetics, MRD risk, relapsed disease, and post CAR T-cell therapy #allsm #leusm #medicalcongress
CONGRESS | #IACH23 | #CoMyDAL
Nicola Goekbuget, @goetheuni presents clinical data on the treatment of T-ALL using GMALL protocols highlighting the need for standardized classification systems and improved treatment options for R/R T-ALL #allsm #leusm
#IACH23 | #CoMyDAL Elias Jabbour,
@MDAndersonNews delivers an interesting talk on the management of Ph-positive ALL, highlighting whether we still need allo-SCT, high efficacy of ponatinib, & new therapies such as olverembatinib currently being explored in this setting #allsm
CONGRESS | #IACH23 | #CoMyDAL Robin Foà @SapienzaRoma gave a presentation on Ph-negative ALL highlighting the key role of MRD monitoring and immunotherapies such as blinatumomab on clinical outcomes
#allsm #leusm
@MSubklewe with a tour-de-force talk on new directions & challenges of immune therapies in #AMLsm & #MDSsm @TheIACH #COMyDAL
@KlausMetzelerMD giving a fantastic talk on resistance mechanics to novel therapies in @IACH #COMyDAL
CONGRESS | #IACH23 | #CoMyDAL
Naval Daver @Daver_Leukemia @LeukemiaMDA reviews firstline therapies for fit patients on behalf of Jessica Altman @jaltmanmd.
· Value of molecular MRD in getting data quickly, and potential to include NGS in regulatory endpoints
· Transplant decisions are dynamic
· Promising trial results of FLAG-Ida-Ven
· High interest in FLT3i including quizartinib, and exciting Aza-ven plus gilteritinib data
@TheIACH #IACH2023 #AMLsm
CONGRESS | #IACH23 | #CoMyDAL
Thomas Cluzeau @thomas_cluzeau @Univ_CotedAzur shares his thoughts on the most promising agents in development:
· IMGN632 plus Aza-Ven backbone
· Gilteritinib plus Aza-Ven backbone
· Magrolimab in TP53m AML
@TheIACH #IACH2023 #amlsm
CONGRESS | #IACH23 | #CoMyDAL
Marion Subklewe @subklewe @LMU_Muenchen describes current immunotherapy landscape in AML and challenges, including target antigen choice. She covers GO as the only currently approved option, antibody-based agents and the need for step-up dosing to mitigate CRS, bispecifics including pre-clinical models with Ven-Aza, and the future of CAR T and NK cells.
@TheIACH #IACH2023 #AMLsm
CONGRESS | #IACH23 | #CoMyDAL
Gail Roboz @WCMLeukemia @nyphospital asks whether adding more agents is better?
· Additive strategy for FLT3 inhibitors on top of baseline agents
· Triplets may not add everywhere, patient decision making needed
· Power triplets and suggestions for OS benefit with FLAG-Ida+Ven, ClIA+Ven
· Unable to do all the randomized studies needed for all patient subgroups and drug combinations
· Excitement over potential menin inhibitor triplets with low and intensive chemo
@TheIACH #IACH2023 #AMLsm
CONGRESS | #IACH23 | #CoMyDAL
Andrew Wei, @PeterMacCC, presents the challenges of treating R/R AML, highlighting 5yr survival still < 10%. He runs through current and potential future therapeutic options, querying what treatment might look like with all the new firstline agents?
@TheIACH #IACH2023 #AMLsm
Outstanding panel discussions on all aspects of #MDSsm in @TheIACH #COMyDAL meeting. What a true pleasure to co-chair the meeting with the one & only dr @Santin13Valeria & have such amazing faculty join us for very robust discussions & debates on how to move the field forward
CONGRESS | #IACH23 | #CoMyDAL
Raphael Itzykson @raphaelitzykson @HopSaintLouis talks describes the need for a clear definition of MDS/AML. He describes therapeutic strategies including the benefit seen with CPX-351 in patients with MDS-type mutations and the potential of HMA+Ven.
@TheIACH #IACH2023 #AMLsm #MDSsm
Last Seen Hashtags on Sotwe
เคสกราดยิงหนองบัวลำภู
Seen from United States
beurette renoi
Seen from France
LivingWellForever
Seen from United States
DownSendromu
Seen from Turkey
massivebuilds
Seen from United States
مطلقة
Seen from Algeria
sex gayviet
Seen from Vietnam
oss
Seen from United States
足协反腐内幕
Seen from Colombia
bbwt
Seen from United States
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.8M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90.1M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers